ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0369

High Frequency of Complications in Axial Spondyloarthropathy Pregnancies: Emerging Data from the Ankylosing Spondylitis Registry of Ireland

Sinead Maguire1, Phil Gallagher2 and Finbar (Barry) O'Shea1, 1St James's Hospital, Dublin, Ireland, 2St Vincent's Hospital, Dublin, Ireland

Meeting: ACR Convergence 2021

Keywords: Ankylosing spondylitis (AS), gender, pregnancy, spondyloarthritis, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Spondyloarthritis Including PsA – Diagnosis, Manifestations, & Outcomes Poster I: Clinical Aspects of Axial Spondyloarthritis (0357–0386)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: National registries are excellent sources of data to allow analysis of inflammatory arthritis such as axial spondyloarthropathy (axSpA). Our understanding of axSpA has evolved rapidly over time resulting in improved recognition of the disease. Unfortunately, for women with axSpA there is limited data on pregnancy outcomes in this population. To address this issue, data was collected on pregnancy within the Ankylosing Spondylitis Registry of Ireland (ASRI), which is a source of epidemiological data on axSpA in Ireland. The aim of this study is to examine the prevalence of pregnancy and fetal complications in females with axSpA.

Methods: The ASRI records information on baseline demographics, imaging, medications, patient outcomes and comorbidities. To be considered for enrolment patients must have been diagnosed with axSpA by a Rheumatologist and meet the ASAS criteria for axSpA. Informed consent was obtained from all patients by a trained investigator, with ethical approval obtained from local hospital ethics committees. A dedicated section within the ASRI collects data on pregnancy, fertility and breastfeeding. Data on these outcomes was then recorded retrospectively for axSpA females enrolled in the ASRI.

Results: At the time of analysis 220 females were enrolled in the ASRI, representing 24.3% of the total population of the registry. Mean age of females was 43.9 years, with a mean disease duration of 18 years and mean delay to diagnosis 7.86 years. 68.6% (151) had radiographic sacoiliitis, while 49.5% (109) had sacroiliitis on MRI. Mean scores for females in the ASRI were: BASDAI 4.6, BASFI 3.82, BASMI, HAQ 0.6, and ASQoL 7.65.

Data on pregnancy was available in 76 women, with 61 women reporting a total of 210 pregnancies resulting in 166 live births. Of these pregnancies 58.1% (122) were uncomplicated and 41.9% (88) were complicated, with 11.4% (24) of pregnancies encountering multiple complications (figure 1).

The frequency of miscarriage was high affecting 20.5% (43) of pregnancies overall in 37.7% (23) of women with a history of pregnancy. Of the pregnancies resulting in live births, the most common pregnancy complication was caesarean section in 10.8% (18) followed by preterm delivery in 11.4% (15), while the most common fetal complication was NICU admission in 11.4% (19) (figure 2). Only 4 women (5.3%) reported difficult conceiving and need for fertility specialist referral, but none underwent assisted reproductive therapy. Prevalence of breastfeeding was low, reported in 33.7% (56) of live births.

Conclusion: Data from the ASRI indicates a high frequency of pregnancy and fetal complications in women with axSpA. These results represent a preliminary analysis of pregnancy outcomes in axSpA pregnancies collected via a large national registry. Ongoing data collection will allow comparison to national averages. This provides much needed insight into the impact of axSpA on pregnancy, which can be used to improve monitoring and management of axSpA women during their pregnancies. Furthermore, data on prevalence of breastfeeding can be used to encourage discussion of benefits and safety while on medication of breastfeeding between Rheumatologists and axSpA women.

Figure 1: Frequency of Complications per Pregnancy

Figure 2: Prevalence of Pregnancy & Fetal Complications in Pregnancies resulting in Live Births


Disclosures: S. Maguire, Gilead, 5; P. Gallagher, None; F. O'Shea, None.

To cite this abstract in AMA style:

Maguire S, Gallagher P, O'Shea F. High Frequency of Complications in Axial Spondyloarthropathy Pregnancies: Emerging Data from the Ankylosing Spondylitis Registry of Ireland [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/high-frequency-of-complications-in-axial-spondyloarthropathy-pregnancies-emerging-data-from-the-ankylosing-spondylitis-registry-of-ireland/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-frequency-of-complications-in-axial-spondyloarthropathy-pregnancies-emerging-data-from-the-ankylosing-spondylitis-registry-of-ireland/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology